Home » International News » 2013 » September » September 9

International News on September 9, 2013

22nd Century Group Announces Allowance of U.S. Patent for Regulating Nicotine in Tobacco with Transcription Factor Gene
22nd Century Group, Inc. (OTCQB: XXII) announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for tobacco plants with altered nicotine content developed by using nucleic acids derived from a transcription factor gene identified as NbTF7 – also known as NbARF1 Business Wire India

Philip Morris International Addresses Misguided Attacks on Role in Tobacco Products Directive Debate
Philip Morris International (PMI) (NYSE/Euronext Paris: PM) today addressed recent attacks on the company’s efforts to express its views on the proposed EU Tobacco Products Directive (TPD). Speaking on behalf of the company, which employs 12,500 people in the EU, generates approximately EUR 14 Business Wire India

Flora Airport Hotel–Kochi has been Awarded the 4-star Hotel Classification
The outstanding hospitality, unique modern design, high quality of food and outlets and superior comfort, are rewarded: the Flora Airport-Kochi has now been officially classified as a 4-star Hotel by the Govt Business Wire India

ZTE Grand Memo LTE Poised to Be China’s First 4G Handset After Permit Award
ZTE’s Grand Memo LTE is poised to become the first 4G device available for sale in China, after it became the first to be awarded a TD-LTE handset permit by the Ministry of Industry and Information Technology. Business Wire India

SMART Communications Selects Thuraya for Crew Calling Service that Keeps Filipino Seafarers in Touch
Thuraya Telecommunications Company, a leading Mobile Satellite Services (MSS) operator, has been selected by SMART Communications of the Philippines for the launch of its new crew calling service, Marino PhonePal. Business Wire India

Spotify chooses Frontier Silicon to support launch of Spotify Connect
Business Wire India

Landmark TIOSPIRTM trial reinforces importance of SPIRIVA® in both available formulations as the world’s leading maintenance therapy for chronic obstructive pulmonary disease (COPD)
For media outside the UK, US and Canada Business Wire India

Phase III results: Once daily olodaterol* Respimat® provides effective and sustained improvements in lung function in patients with COPD1-3
Business Wire India

Phase III data presented for first time demonstrate: tiotropium* Respimat® significantly improves lung function and provides sustained bronchodilation in asthma patients who remain symptomatic despite ICS treatment1
Business Wire India

Comment on this story